Cushman & Wakefield Announces Director Changes and Compensation Details
Ticker: CWK · Form: 8-K · Filed: Mar 18, 2024 · CIK: 1628369
Sentiment: neutral
Topics: board-changes, executive-compensation, governance
TL;DR
Cushman & Wakefield board shakeup: MacKay out, Smith in, exec pay details disclosed.
AI Summary
Cushman & Wakefield plc announced on March 12, 2024, the departure of director Michelle MacKay and the appointment of Andrew Smith as a new director. The company also disclosed compensatory arrangements for certain officers, details of which are provided in the filing.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy or governance, impacting investor confidence and future performance.
Risk Assessment
Risk Level: low — The filing primarily concerns routine board and officer changes and compensation disclosures, which are common and generally do not indicate significant operational risks.
Key Players & Entities
- Cushman & Wakefield plc (company) — Registrant
- Michelle MacKay (person) — Departing Director
- Andrew Smith (person) — Appointed Director
- March 12, 2024 (date) — Date of earliest event reported
FAQ
Who has departed from the board of directors at Cushman & Wakefield plc?
Michelle MacKay has departed from the board of directors.
Who has been appointed as a new director to the board of Cushman & Wakefield plc?
Andrew Smith has been appointed as a new director.
What is the exact date of the earliest event reported in this 8-K filing?
The earliest event reported is dated March 12, 2024.
What specific items are covered under the 'ITEM INFORMATION' section of this filing?
The filing covers 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers', 'Regulation FD Disclosure', and 'Financial Statements and Exhibits'.
What is the company's jurisdiction of incorporation and fiscal year end?
The company is incorporated in England and Wales, and its fiscal year ends on December 31.
Filing Stats: 1,414 words · 6 min read · ~5 pages · Grade level 9.8 · Accepted 2024-03-18 17:11:31
Key Financial Figures
- $0.10 — on which registered Ordinary shares, $0.10 nominal value CWK New York Stock Ex
Filing Documents
- d783313d8k.htm (8-K) — 31KB
- d783313dex991.htm (EX-99.1) — 7KB
- g783313cw.jpg (GRAPHIC) — 8KB
- 0001193125-24-070244.txt ( ) — 170KB
- cwk-20240312.xsd (EX-101.SCH) — 3KB
- cwk-20240312_lab.xml (EX-101.LAB) — 17KB
- cwk-20240312_pre.xml (EX-101.PRE) — 11KB
- d783313d8k_htm.xml (XML) — 3KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. The following exhibits are filed as part of this report: Exhibit No. Description 99.1 Press Release dated March 18, 2024. 104 Cover Page Interactive Data File (formatted as Inline XBRL).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: March 18, 2024 CUSHMAN & WAKEFIELD PLC By: /s/ Noelle Perkins Name: Noelle Perkins Title: Executive Vice President, General Counsel and Corporate Secretary